4//SEC Filing
Rosenstein Alexander 4
Accession 0001062993-23-009594
CIK 0001180145other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:32 PM ET
Size
6.9 KB
Accession
0001062993-23-009594
Insider Transaction Report
Form 4
Rosenstein Alexander
General Counsel & Corp. Secy
Transactions
- Disposition to Issuer
Common Stock
2023-04-27$20.00/sh−107,700$2,154,000→ 40,973 total - Disposition to Issuer
Common Stock
2023-04-27$20.00/sh−40,973$819,460→ 0 total
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. Shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.
- [F2]Converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes.
Issuer
Cardiovascular Systems Inc
CIK 0001180145
Entity typeother
Related Parties
1- filerCIK 0001680771
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 4:32 PM ET
- Size
- 6.9 KB